A Study of MK-4827 in Combination With Standard Chemotherapy in Participants With Advanced Solid Tumors (MK-4827-008 AM1)

NCT01110603 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer: Solid Tumors

Interventions

DRUG: MK-4827
DRUG: carboplatin
DRUG: paclitaxel
DRUG: liposomal doxorubicin

Sponsor

Tesaro, Inc.